Response to richardson and potter’s “screening for colorectal cancer and prostate cancer: Challenges for New Zealand”—with authors’ reply

New Zealand Medical Journal

Volumn 127, Issue 1397, 2014, Pages 102-104

  Sarfati, Diana ^a   Bissett, Ian ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; HUMAN; LETTER; NEW ZEALAND; OCCULT BLOOD TEST; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGMOIDOSCOPY; COLORECTAL TUMOR; FEMALE; MALE; MASS SCREENING; PROSTATE TUMOR;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; PROSTATIC NEOPLASMS;

EID: 84925227929     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Richardson A, Potter JD. Screening for colorectal cancer and prostate cancer: challenges for New Zealand. N Z Med J 2014;127(1395). http://journal.nzma.org.nz/journal/127-1395/6149/
2. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375(9726):1624-33.
3. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59(1):62-8.
4. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Annals of Internal Medicine 2014;160(3):171.
5. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149(9):659-69.
6. Health Information and Quality Authority. Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland. Ireland: Health Information and Quality Authority, 2009.
7. Whyte S, Chilcott J, Cooper K, et al. Re-appraisal of the options for colorectal cancer screening: FULL REPORT. Sheffield: School of Health and Related Research, Sheffield University, 2011.
8. Church TR. Screening for colorectal cancer--which strategy is the best? J Natl Cancer Inst 2011;103(17):1282-3.
9. Flitcroft KL, Irwig LM, Carter SM, et al. Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterol 2012;12:183.